MRI Predicts Response to VEGF Inhibitor in Recurrent Glioblastoma MRI Predicts Response to VEGF Inhibitor in Recurrent Glioblastoma

Predicting the response to therapy comes down to contrast enhancing patterns on the pretreatment MRI, a new study suggests. The study was published as a preprint and has not yet been peer reviewed.First Look
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news